28 research outputs found
RECENT PATENTS.
- Publication venue
- 'American Chemical Society (ACS)'
- Publication date
- Field of study
No full textDetermination of molybdenum in biological materials with 2-amino-4-chlorobenzenethiol
- Author
- Publication venue
- 'Wiley'
- Publication date
- Field of study
No full textIdentification and Structural Elucidation of New Process Impurity in Testosterone
- Author
- Publication venue
- 'Oxford University Press (OUP)'
- Publication date
- Field of study
No full textPurity of Medicinal Products
- Author
- GM Cramer
- IC Munro
- Impurities in New Drug Substances CPMP/ICH/ 142/95.
- Impurities in New Medicinal Products
- Impurities: Residual Solvents
- Non Clinical Safety Studies for the Conduct of Human Clinical Trials for Pharmaceuticals
- Notice to Applicants. The Rules Governing Medicinal Products in the European Union.
- Specifications: Test ProceduresAcceptance Criteria for New Drug SubstancesNew Drug Products: Chemical Substances
- Summary of Requirements for Active Substances in Part II of the Dossier
- Publication venue
- 'SAGE Publications'
- Publication date
- Field of study
No full textSuccessful Development by Design of Experiments of a Gas Chromatography Method for Simultaneous Analysis of Residual Solvents of Classes 1 and 2
- Author
- Publication venue
- 'Oxford University Press (OUP)'
- Publication date
- Field of study
No full textPharmaceutical impurities—A mini-review
- Author
- A Smith
- British Pharmacopoeia
- Food and Drug Administration for immediate release consumer media
- G. Condorelli
- GJA Walker
- HV Hogerzeil
- International Conferences on Harmonization Draft Revised Guidance on Impurities in New Drug Products. Q3B(R)
- International Conferences on Harmonization Draft Revised Guidance on Impurities in New Drug Substances. Q3A(R)
- International Conferences on Harmonization Impurities--Guidelines for Residual Solvents
- J Roy
- J Roy
- J Roy
- J Sunderland
- J. Roy
- Jiben Roy
- KA Connor
- KM Alsante
- MM Hoq
- PC Krimpen Van
- S Ahuja
- S Gorog
- TN Riley
- V Buhler
- V Kumar
- Publication venue
- 'American Association of Pharmaceutical Scientists (AAPS)'
- Publication date
- Field of study
No full textA survey of methods of analysis for minerals in feedstuffs1,2
- Author
- Abbey
- Allen
- American Public Health Association
- Analytical Methods Committee Metallic Impurities in Organic Matter Sub-Committee
- Analytical Methods Committee Metallic Impurities in Organic Matter Sub-Committee
- Analytical Methods Committee Metallic Impurities in Organic Matter Sub-Committee
- Analytical Methods Committee Metallic Impurities in Organic Matter Sub-Committee
- Analytical Methods Committee Metallic Impurities in Organic Matter Sub-Committee
- Analytical Methods Committee Metallic Impurities in Organic Matter Sub-Committee
- Analytical Methods Committee Metallic Impurities in Organic Matter Sub-Committee
- Analytical Methods Committee Sub-Committee of the Analytical Methods Committee and the Association of Official Analytical Chemists
- AOAC
- Approved Methods Committee
- ASTM Committee E-2 on Analytical Atomic Spectroscopy
- Begheijn
- Cali
- Coles
- Comité Inter-Instituts d'Etude des Techniques Analytiques du Diagnostic Foliaire (CII)
- Dabeka
- Evenson
- Falchuk
- Firestone
- Gavlak
- Hanlon
- Hart
- Horwitz
- Ihnat
- Ihnat
- Ihnat
- Ihnat
- Ihnat
- Ihnat
- Ihnat
- Institute of Brewing Analysis CommitteeMartin (chairman)
- Institute of Brewing Analysis CommitteeWeiner (chairman)
- Institute of Brewing Analysis CommitteeWeiner (chairman)
- International Association for Cereal Science and Technology
- International Association for Cereal Science and Technology
- International Dairy Federation
- Japan Tea Research Station
- Kalra
- Kellems
- Lees
- M. Ihnat
- Marshall
- Martin
- Mercury Analysis Working Party of the Bureau International Technique du Chlore
- Ministry of Agriculture Fisheries and Food
- National Shellfish Sanitation Program (Subcommittee on Procedures of the Chemistry Task Force)
- Pearson
- Pinta
- Pinta
- Pires
- Richards
- Schuller
- Velapoldi
- Velapoldi
- Watson
- Publication venue
- 'American Society of Animal Science (ASAS)'
- Publication date
- Field of study
No full textGuidelines and strategy of the International Conference of Harmonization (ICH) and its member states to overcome existing impurity control problems for antibiotics in China
- Author
- Publication venue
- 'Elsevier BV'
- Publication date
- Field of study
No full textIntroduction
- Author
- Analysis of the Expression Construct in Cells Used for Production of r-DNA Derived Protein Products (Q5B)
- Analytical Procedure Development (Q14)
- Assessment and Control of DNA Reactive (Mutagenic) Impurities in Pharmaceuticals to Limit Potential Carcinogenic Risk (M7)
- Bioanalytical Method Validation (M10)
- Biopharmaceutics Classification System-based Biowavers (M9)
- Bracketing and Matrixing Design for Stability Testing: New Drug Substances and Products (Q1D)
- Brown
- Comparability of Biotechnological/Biological Products Subject to Changes in their Manufacturing Process (Q5E)
- Continuous Manufacturing of Drug Substances and Drug Products (Q13)
- Derivation and Characterisation of Cell Substrates Used for Production of Biotechnological/Biological Products (Q5D)
- Development and Manufacture of Drug Substances (Q11)
- Electronic Common Technical Document (eCTD) (M8)
- Evaluation of Stability Data (Q1E)
- Good Manufacturing actice Guide for Active Pharmaceutical Ingredients (Q7)
- Impurities in New Drugs Products (Q3B(R2))
- Impurities in New Drugs Substances (Q3A(R2))
- Impurities: Guideline for Elemental Impurities (Q3D(R1))
- Impurities: Guideline for Residual Solvents (Q3C(R7))
- Pharmaceutical Development (Q8(R2))
- Pharmaceutical Quality System (Q10(R4))
- Quality Risk Management (Q9)
- Specifications: Test Procedures and Acceptance Criteria for Biotechnological/Biological Products (Q6B)
- Specifications: Test Procedures and Acceptance Criteria for New Drug Substances and New Drug Products: Chemical Substances (Q6A)
- Stability Data Package for Registration Applications in Climatic Zones III and IV (Q1F)
- Stability Testing of Biotechnological/Biological Products (Q5C)
- Stability Testing of New Substances and Products (Q1A(R2))
- Stability Testing: New Dosage Forms (Q1C)
- Stability Testing: Photostability Testing of New Drug Substances and Products (Q1B)
- Technical and Regulatory Considerations for Pharmaceutical Product Lifecycle Management (Q12)
- The Common Technical Document for the Registration of Pharmaceuticals for Human Use: Quality – M4Q(R1)
- Validation of Analytical Procedures: Text and Methodology (Q2(R1))
- Viral Safety Evaluation of Biotechnology Products Derived from Cell Lines of Human or Animal Origin (Q5A(R1))
- Publication venue
- 'Elsevier BV'
- Publication date
- 01/01/2020
- Field of study
No full text
